perjeta 420mg14ml concentrate for solution for infusion vials
roche products ltd - pertuzumab - solution for infusion - 30mg/1ml
etoposide 100mg/5ml concentrate for solution for infusion vials
accord-uk ltd - etoposide - solution for infusion - 20mg/1ml
etoposide 100mg/5ml concentrate for solution for infusion vials
actavis uk ltd - etoposide - solution for infusion - 20mg/1ml
mycophenolate mofetil 500mg powder for concentrate for solution for infusion vials
accord healthcare ltd - mycophenolate mofetil hydrochloride - powder for solution for infusion - 500mg
victoza 6mgml solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - liraglutide -
human albumin baxalta 50 g/l inf. sol. i.v. vial
baxalta innovations gmbh - albumin human 50 g/l - solution for infusion - 50 g/l - albumin human 50 mg/ml - albumin
xultophy
novo nordisk ltd., israel - insulin degludec; liraglutide - solution for injection - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide - xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1
human albumin csl behring 200 g/l inf. sol. i.v. vial
csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin
human albumin csl behring 200 g/l inf. sol. i.v. vial
csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin
albumin human 200g/l 200 g/l solution for infusion
octapharma limited - albumin human - solution for infusion - 200 g/l